Accelerate to Discover

Back to filter

Related topics

Early fetal sex determination using micro-volume of maternal plasma

BJS Biotechnologies

Jun 16, 2018

 A qPCR-based assay, SneakPeek Early Gender Test (Gateway Genomics) has been developed to determine fetal sex as early...

3R Compliant drug development studies

Bruker Biospin

Jun 8, 2018

In preclinical imaging, magnetic resonance imaging (MRI) can be an attractive alternative to researchers who have...

Kinase study of cytotoxicity voted paper of the year.

Acea Biosciences

Jun 6, 2018

Society of Toxicology voted a xCELLigence based paper the Paper of the Year. The study of cytotoxicity was done using...

Heterodimeric compounds with dual-targeting active against both HIV and tuberculosis.

Acea Biosciences

Jun 4, 2018

Search for dual action drugs against both HIV and Tuberculosis has lead to the creation of heterodimeric compounds with...

Jun 18, 2018

Mutual destruction of deep Lung tumor tissues by nanodrug‐conjugated and CQ1 imaging cytometer

Yokogawa

Jun 1, 2018

Lung cancer is a highly malignant tumor, and targeted delivery of anti‐cancer drugs to deep lung tumor tissue remains a...

Method to quantify local force distribution within biomolecular systems

LUMICKS

May 24, 2018

The journal Nano Letters has recently published the article “Quantifying Local Molecular Tension Using Intercalated DNA...

Bionano fall user workshop

BioNano Genomics

May 23, 2018

We are happy to announce the Bionano Genomics’ 2018 user workshop taking place in San Diego on October 15-16,...

Jun 18, 2018

Registering FDG/PET mouse and AMYViD/PET-CT rat studies to brain VOI atlases

Bruker Biospin

May 22, 2018

Preclinical NeuroPET is employed widely in studies of stroke, ischemia, addiction and eurodegenerative diseases. In...

Show all topics (10)

Attana biosensors at the University of Birningham

Jun 17, 2016

Under the supervision of Professor Eugenia (Éva) Valsami-Jones and Dr. Iseult Lynch, the Environmental Nanosciences group aims at understanding reactivity at the nanoscale, and how this impacts on processes such as biomineralisation, environmental transformation and ageing, and nanoparticle interactions with organisms. In particular, the group focuses on:

- Nanoparticle interactions with biomolecules in the environment (natural organic matter, secreted proteins, organic pollutants, etc.) – investigating the “eco-corona” and secondary pollutant effects.

- Determination of the fate and behavior of nanomaterials in the environment.

- Development of high throughput screening applications: nano(eco)toxicology, bionanointeractions and assessment of environmental fate of nanomaterials.

The group will use the Attana instrument to characterize nanoparticle behaviour in different environments and to develop an assessment and prediction tool for nanoparticle behavior, including dissolution, homo and heteroagglomeration and binding of environmentally relevant biomolecules and macromolecules.

“The Attana Cell 200 will be a vital instrument to characterize and understand nanoscale materials, which can behave in novel and unexpected ways. Their very small size and exceptionally high surface area to volume ratio are features that alter their properties enormously. This results in a high reactivity and a large area onto which biomolecules and other environmental entities can bind. The kinetic interaction analysis enabled by the Attana Cell 200 is essential to understand and safely utilize nanoproperties for a range of environmental applications” comments Dr. Lynch.

Attana CSO, Teodor Aastrup adds, “Environmental Nanosciences at University of Birmingham is one of the leading groups in nanoparticle characterization and we are excited about the Attana instrument being part of their important research. It is yet another confirmation of the importance of understanding the kinetic interactions in complex and realistic environments.”

Application
Product news

Related technologies: Single-molecule Interactions

Brand profile

Attana

Attana biosensors provides a reliable, fast and versatile label-free method to study molecular interactions.

Related products

The label-free biosensor that combines biochemical and cell-based assays.

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey